Prognostic Factors for Mortality among Day +100 Survivors after Allogeneic Hematopoietic Cell Transplantation
Authors:
Open Access
- 1 May 2018
- journal article
- research article
- Published by Elsevier in Transplantation and Cellular Therapy
- Vol. 24 (5) , 1029-1034
Abstract
No abstract availableKeywords
This publication has 31 references indexed in Scilit:
- Readmissions after Umbilical Cord Blood Transplantation and Impact on Overall SurvivalTransplantation and Cellular Therapy, 2017
- Patient-Reported Outcomes and Socioeconomic Status as Predictors of Clinical Outcomes after Hematopoietic Stem Cell Transplantation: A Study from the Blood and Marrow Transplant Clinical Trials Network 0902 TrialTransplantation and Cellular Therapy, 2016
- Scoring System Prognostic of Outcome in Patients Undergoing Allogeneic Hematopoietic Cell Transplantation for Myelodysplastic SyndromeJournal of Clinical Oncology, 2016
- Modified EBMT Pretransplant Risk Score Can Identify Favorable-risk Patients Undergoing Allogeneic Hematopoietic Cell Transplantation for AML, Not Identified by the HCT-CI ScoreClinical Lymphoma Myeloma and Leukemia, 2015
- Risk Factors for Readmission after Allogeneic Hematopoietic Stem Cell Transplantation and Impact on Overall SurvivalTransplantation and Cellular Therapy, 2015
- Allogeneic Hematopoietic Cell Transplantation for Acute Myeloid LeukemiaTransplantation and Cellular Therapy, 2015
- Peripheral-Blood Stem Cells versus Bone Marrow from Unrelated DonorsNew England Journal of Medicine, 2012
- Outcomes of Hematologic Malignancies after Unrelated Donor Hematopoietic Cell Transplantation According to Place of ResidenceTransplantation and Cellular Therapy, 2010
- Transplants of Umbilical-Cord Blood or Bone Marrow from Unrelated Donors in Adults with Acute LeukemiaNew England Journal of Medicine, 2004
- Inequality in QualityJAMA, 2000